Curbo, Rotchelyn O.
HRN: 21-81-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
CEFUROXIME 500MG (TAB)
08/16/2022
08/22/2022
ORAL
500mg
BID
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes